Surviving Pneumonia
ConditionCommunity-acquired Pneumonia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNordsjaellands Hospital
About this trial
The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.
Eligibility criteria
Qualifiers
Fever (temperature, ≥38.0°C)
Hypothermia (<35.0°C),
New cough with or without sputum production
Pleuritic chest pain
Disqualifiers
Patients unable to give informed consent
Patients unwilling to give informed consent
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
2,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov